Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05235932

the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer

A Prospective, Multicenter, Randomized, Controlled Study of the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
570 (estimated)
Sponsor
Fujian Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To evaluate the clinical efficacy (safety, feasibility and long-term efficacy) of robotic radical total gastrectomy and laparoscopic radical total gastrectomy in patients with locally advanced middle and upper gastric adenocarcinoma (CT2-4A, N-/+, M0) .

Detailed description

In the field of gastrectomy, Hashizume et al. first reported robotic gastrectomy in 2002. Since then, reports on the safety and feasibility of the application of robotic surgical system in the treatment of gastric cancer (GC) have gradually increased. Reports of robotic surgery for GC are increasing, especially in Asia. Several studies confirmed the advantages of robotic gastrectomy when compared with laparoscopic gastrectomy. However, whether robotic radical total gastrectomy is noninferior to laparoscopic radical total gastrectomy remains unclear. The investigator first carried out this study in the world to evaluate the efficacy of robotic radical total gastrectomy versus laparoscopic radical total gastrectomy for GC.

Conditions

Interventions

TypeNameDescription
PROCEDURERobotic radical total gastrectomy with D2 lymphadenectomyMost surgical procedures are performed using the robot system.
PROCEDURELaparoscopic radical total gastrectomy with D2 lymphadenectomyWithout the robot system, Most surgical procedures are performed using laparoscopic equipment.

Timeline

Start date
2022-02-20
Primary completion
2024-02-20
Completion
2027-02-20
First posted
2022-02-11
Last updated
2022-02-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05235932. Inclusion in this directory is not an endorsement.